<DOC>
	<DOCNO>NCT01698489</DOCNO>
	<brief_summary>Closer examination granular lipid data large population offer numerous opportunity generate new knowledge , range study examine concordance commonly use lipid parameter phenotypic characterization rare extreme disorder lipid metabolism , open possibility well personalize future treatment abnormal blood lipid . STUDY POPULATION : The Very Large Database Lipids ( VLDL ) include adults child clinically refer Vertical Auto Profile ( VAP ) . LIPID MEASUREMENTS : The VAP test ( Atherotech , Birmingham , Alabama , USA ) directly measure cholesterol concentration low density lipoprotein , low density lipoprotein , intermediate density lipoprotein , high density lipoprotein , subfractions , lipoprotein ( ) . Triglycerides database directly measure use Abbott ARCHITECT C‚Äê8000 system ( Abbott Park , Illinois , USA ) . Lipid distribution database closely match population-representative National Health Nutrition Examination Survey ( NHANES ) 2007-2008 . STUDY PROCEDURES : This database investigator-initiated . Only de-identified data reach investigational site . The first data harvest 2011 , encompass 1,350,908 sample . The second harvest underway ; thus far , updated database suit assess seasonal variation establish 2,859,333 sample . The master database house The Johns Hopkins Hospital Baltimore , Maryland , maintain Drs . Jones Martin . Only electronic data , biospecimens , send Hopkins . The academic investigator unrestricted access study data , take responsibility accuracy analysis , authority manuscript preparation submission . VARIABLES : The variable currently VLDL database test date , age , sex , low density lipoprotein , low density lipoprotein , intermediate density lipoprotein , high density lipoprotein , subfractions , lipoprotein ( ) , LDL pattern . From primary variable , many additional variable derive inclusion master database ( e.g. , non-HDL-C , Friedewald LDL-C , TC/HDL-C , etc. ) . Other analytes measure validated assay subset VLDL database include apoB , apoA1 , hsCRP , homocysteine , uric acid , insulin , hemoglobin A1c , 25-hydroxy vitamin D , cystatin C , Lp-PLA2 , TSH , free T3 T4 , pro-BNP , direct bilirubin , CPK , creatinine component comprehensive metabolic panel , magnesium , phosphate . DATABASE ORGANIZATION : In current database , record represent unique patient . The 1st available VAP test patient include . To meet needs variety research question , prospectively plan organize harvest 2 data 3-year interval datasets ( i.e. , VLDL 2006-2008 , 2009-2011 , VLDL 2012-2014 , etc ) , summation dataset ( first VAP test patient ) , serial lab dataset ( patient repeat test ) , ancillary datasets ( subset patient coexist data measure apolipoproteins , vitamin D , hs-CRP , TSH/T4 , etc ) . INDIVIDUAL STUDIES : Individual VLDL study base priori hypothesis aim statistical analysis plan ( SAPs ) peer-reviewed prior execution . In expandable `` Detailed Description '' section , VLDL investigator periodically register individual study update status clinicaltrials.gov .</brief_summary>
	<brief_title>The Very Large Database Lipids ( VLDL )</brief_title>
	<detailed_description>REGISTRATION &amp; STATUS OF VLDL STUDIES - VLDL-1A : Friedewald Estimated versus Directly Measured Low-Density Lipoprotein Cholesterol Treatment Implications ( abstract present ; manuscript publish ; citation provide ) - VLDL-1B : Comparison Novel Method v Friedewald Equation Estimating Low-Density Lipoprotein Cholesterol Levels Standard Lipid Profile . ( manuscript publish ; citation provide ) - VLDL-1C : Low-Density Lipoprotein Cholesterol Estimation Very Low Levels Clinical Implications ( abstract accept presentation ; manuscript preparation ) - VLDL-2A : Non-High-Density Lipoprotein Cholesterol , Guideline Targets , Population Percentiles Secondary Prevention ( abstract present ; manuscript publish ; citation provide ) - VLDL-2B : Patient-Level Discordance Population Percentiles Total Cholesterol High-Density Lipoprotein Cholesterol Ratio Comparison With Low-Density Lipoprotein Cholesterol Non-High-Density Lipoprotein Cholesterol ( abstract present ; manuscript publish ; citation provide ) - VLDL-3 : Deficient Serum 25-Hydroxy Vitamin D Associated Atherogenic Lipid Profile ( abstract present ; manuscript publish ; citation provide ) - VLDL-4 : Relationship Triglyceride High-Density Lipoprotein Cholesterol ( TG/HDL-C ) Ratio Remainder Lipid Profile ( abstract present ; manuscript publish ; citation provide ) - VLDL-5 : Ratio Dense Buoyant LDL Subclass LDL Density Phenotype ( abstract present ; manuscript publish ; citation provide ) - VLDL-6 : Characterization Fredrickson-Levy Dyslipidemia Classes without Chylomicrons ( IIa , IIb , III , IV ) ( abstract present ; manuscript preparation ) - VLDL-7 : Characterization Fredrickson-Levy Dyslipidemia Classes Chylomicrons ( I , V ) ( abstract present ; manuscript preparation ) - VLDL-8 : Continuum Non-Chylomicron Dyslipidemia Phenotype Classifiable Fredrickson-Levy Criteria ( abstract present ; manuscript preparation ) - VLDL-9 : Lipid Phenotypes Extremes High-Density Lipoprotein Cholesterol ( abstract present ; manuscript publish ; citation provide ) - VLDL-10A : Atherogenic Lipid Levels 662,711 Elderly Persons : The Very Large Database Lipids 10A ( abstract present ; manuscript preparation ) - VLDL-10B : Narrowing Sex Differences Lipoprotein Cholesterol Subclasses Following Mid-Life ( abstract present ; manuscript publish ; citation provide ) - VLDL-11 : Exploration individual AHA ideal total cholesterol ( &lt; 200 mg/dL ) ( statistical analysis plan development ) - VLDL-12 : Extremely low LDL-C , non-HDL-C phenotype ( statistical analysis plan development ) - VLDL-13 : Thyroid function vs. lipid ( abstract present ; manuscript preparation ) - VLDL-14 : Seasonal variation lipid biomarkers ( abstract present ; manuscript preparation ) - VLDL-15 : Lipids , hsCRP , Lp ( ) , LpPLA2 : phenotype , lipid oxidation , inflammation ( statistical analysis plan development ) - VLDL-16 : Secular trend MetSyn lipid criterion , RLP-C ( statistical analysis plan development ) - VLDL-17 : Screening familial hypercholesterolemia ( abstract present ; manuscript publish ; citation provide ) - VLDL-18 : RLP-C definition ( statistical analysis plan development ) - VLDL-19 : Lipoprotein ( ) familial hypercholesterolemia ( statistical analysis plan development ) - VLDL-20 : Lipoprotein subfractions uric acid ( abstract preparation ) - VLDL-21 : Lipoprotein subfractions homocysteine ( abstract preparation ) - VLDL-22 : Lipoprotein ( ) , HDL-C , TG ( abstract preparation ) - VLDL-23 : Dual LDL-C hs-CRP target attainment ( statistical analysis plan development )</detailed_description>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Patients age lipid data include master database . Eligibility criterion specific individual study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>